The Harriet Lane Handbook: A Manual for Pediatric House OfficersMichael A. Barone, Johns Hopkins Hospital. Children's Medical and Surgical Center This practical, pocket-sized guide to the pediatric market is presented in a modified outline format with diagnostic guidelines, recommended tests, therapeutics, and dosage schedules. Charts, tables and figures make the information readily accessible. New information is provided on adolescent medicine, blood smear evaluation, outpatient management of illness, pain and sedation, infectious diseases, and immunoprophylaxis. |
From inside the book
Results 1-3 of 49
Page 45
... iron concentration 2-6 hours after ingestion ( time of peak concentration varies with iron product ingested ) . A level > 350 mcg / dl is frequently associated with systemic toxicity . Note : However , serum iron levels obtained at any ...
... iron concentration 2-6 hours after ingestion ( time of peak concentration varies with iron product ingested ) . A level > 350 mcg / dl is frequently associated with systemic toxicity . Note : However , serum iron levels obtained at any ...
Page 556
... IRON DEXTRAN- ( cont . ) IRON PREPARATIONS ( Fergon , Fer - In - Sol , Ferralet , Feosol , and others ) Oral iron supplements Ferrous sulfate ( 20 % elemental Fe ) : Drops ( Fer - In - Sol ) : 75 mg ( 15 mg Fe ) /0.6 ml ( 50 ml ) Syrup ...
... IRON DEXTRAN- ( cont . ) IRON PREPARATIONS ( Fergon , Fer - In - Sol , Ferralet , Feosol , and others ) Oral iron supplements Ferrous sulfate ( 20 % elemental Fe ) : Drops ( Fer - In - Sol ) : 75 mg ( 15 mg Fe ) /0.6 ml ( 50 ml ) Syrup ...
Page 739
... iron dextran for , 555 iron preparations for , 556 Iron dextran , 555-556 Iron overload , chronic , deferoxamine mesylate for , 518 Iron poisoning , 44–46 acute , deferoxamine mesylate for , 518 Iron preparations , 556-557 Iron trial ...
... iron dextran for , 555 iron preparations for , 556 Iron dextran , 555-556 Iron overload , chronic , deferoxamine mesylate for , 518 Iron poisoning , 44–46 acute , deferoxamine mesylate for , 518 Iron preparations , 556-557 Iron trial ...
Other editions - View all
Common terms and phrases
abnormal acid activity acute administration Adult artery Assessment blood body cardiac catheter cause cells Chapter child clinical Consider Continued contraindicated decreased deficiency diagnosis disease disorders drug effects electrolyte emergency evaluation fluid function gestational age Give given glucose growth head heart hepatic hypothyroidism immunization increase Indications infants infection infusion ingestion Initial injury interval iron LEAD levels losses Management max dose mcmol/L Measures mEq/L method mg/dl mg/dose mg/kg mg/kg/dose mg/ml minutes Monitor months needed neonates Newborn normal Note Obtain occur Oral patients Pediatr percentile positive present pressure procedure prophylaxis protein pulmonary Q6 hr recommended reduce renal respiratory risk seizures serum severe side solution specific symptoms syndrome TABLE Tabs therapy tion toxicity treated treatment tube urine usually vaccine volume wave weeks weight